# Cocaine, amphetamine, or titin: Unraveling the genetic underpinnings of dilated cardiomyopathy

## TL;DR

This case report shows how genetic testing identified a TTN gene mutation in a patient with unexplained heart disease, highlighting the importance of genetics in diagnosing and managing cardiomyopathy.

## Contribution

The paper emphasizes the role of TTN gene mutations in dilated cardiomyopathy and advocates for integrating genetic testing with lifestyle factors in clinical practice.

## Key findings

- A TTN gene mutation was identified as a key genetic factor in the patient's dilated cardiomyopathy.
- The case underscores the importance of genetic counseling and testing for at-risk relatives.
- Combining genetic and lifestyle assessments can improve diagnosis and personalized management of cardiomyopathy.

## Abstract

An interesting case that shows the importance of identifying a pathogenic TTN gene mutation through genetic assessment in unexplained cardiomyopathy, especially with family history. This case highlights the need for genetic counseling and testing for at‐risk relatives, and advocates for personalized management considering both genetic and lifestyle factors.

This case report examines a 33‐year‐old Hispanic male with bipolar disorder, schizophrenia, and a history of substance use, presenting with acute respiratory failure and cardiac arrest. The patient's nonischemic dilated cardiomyopathy (DCM) highlights the critical role of genetic factors, particularly titin gene (TTN) mutations, in cardiomyopathy pathogenesis. Through genetic analysis, we explore the intersection of lifestyle factors and genetic predisposition in DCM, underscoring the importance of comprehensive genetic testing for accurate diagnosis and targeted therapy. This case contributes to the evolving understanding of DCM etiology, emphasizing the necessity of considering both environmental and genetic factors in clinical assessment and management.